Coeliac Disease Clinical Trials

An estimated 1 in 70 Australians have coeliac disease, an autoimmune condition triggered by gluten proteins found in wheat, rye and barley, which causes the immune system to attack the small intestine. However, it is estimated that more than 80 per cent of all Australian coeliac sufferers remain undiagnosed.

Patients with coeliac disease can experience a wide range of symptoms. Signs include abdominal pain, bloating, diarrhea, constipation, fatigue and weight loss, although many are now diagnosed on the basis of other symptoms such as iron deficiency, short stature, tooth enamel defects and migraines.

If left untreated, coeliac disease is associated with a three-fold increase in the risk of autoimmune diseases and osteoporosis, as well as a decreased quality of life, and an increase in mortality. The disease can lead to increased risks of nutrient deficiencies, malignancy and unnecessary healthcare costs.

You can help progress coeliac disease research!  If you or someone you know has coeliac disease, they may be eligible to take part in clinical trials.  Through participating in a clinical trial, you are directly helping the community to access better diagnostics, improved treatments and enhanced management of this disease. 

The Clinical Trials Centre at Wesley Research Institute has been managing trials since 1994, and is located within the Wesley Hospital.

About You

• Are aged 18-65 years
• Have a coeliac disease diagnosis
• On a gluten-free diet
• Live within the greater Brisbane region, Gold Coast, Sunshine Coast or surrounds

Interested? Register your interest below.